Prime Medicine (PRME) Accumulated Depreciation & Amortization (2021 - 2025)
Historic Accumulated Depreciation & Amortization for Prime Medicine (PRME) over the last 5 years, with Q3 2025 value amounting to $1.9 million.
- Prime Medicine's Accumulated Depreciation & Amortization rose 2073.17% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 2073.17%. This contributed to the annual value of $6.1 million for FY2024, which is 3170.0% up from last year.
- Latest data reveals that Prime Medicine reported Accumulated Depreciation & Amortization of $1.9 million as of Q3 2025, which was up 2073.17% from $1.9 million recorded in Q2 2025.
- Prime Medicine's 5-year Accumulated Depreciation & Amortization high stood at $6.1 million for Q4 2024, and its period low was $200000.0 during Q3 2021.
- In the last 5 years, Prime Medicine's Accumulated Depreciation & Amortization had a median value of $1.3 million in 2024 and averaged $1.7 million.
- As far as peak fluctuations go, Prime Medicine's Accumulated Depreciation & Amortization skyrocketed by 27066.67% in 2022, and later soared by 2073.17% in 2025.
- Quarter analysis of 5 years shows Prime Medicine's Accumulated Depreciation & Amortization stood at $600000.0 in 2021, then soared by 270.67% to $2.2 million in 2022, then skyrocketed by 109.22% to $4.7 million in 2023, then skyrocketed by 31.7% to $6.1 million in 2024, then crashed by 69.3% to $1.9 million in 2025.
- Its last three reported values are $1.9 million in Q3 2025, $1.9 million for Q2 2025, and $1.7 million during Q1 2025.